SCHEMBL5165239

SCHEMBL5165239

CNc1c(C(=O)N(C)c2ccccc2)c(=O)n(C)c2cccc(C)c12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 6/20 0.56
▸ KMT2A Q03164 6/20 0.56
▸ PGR P06401 1/20 0.56
▸ SRC P12931 1/20 0.48
▸ HDAC4 P56524 1/20 0.45
▸ MAP3K5 Q99683 2/20 0.41
▸ POLB P06746 2/20 0.39
▸ PABPC1 P11940 1/20 0.39
▸ L3MBTL1 Q9Y468 2/20 0.38
▸ TP53 P04637 2/20 0.37
▸ GABRP O00591 1/20 0.36
▸ GABRD O14764 1/20 0.36
▸ GABRA1 P14867 1/20 0.36
▸ GABRB1 P18505 1/20 0.36
▸ GABRG2 P18507 1/20 0.36
▸ GABRB3 P28472 1/20 0.36
▸ GABRA5 P31644 1/20 0.36
▸ GABRA3 P34903 1/20 0.36
▸ GABRA2 P47869 1/20 0.36
▸ GABRB2 P47870 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5180583 0.88 MEN1 (0.56) MEN1KMT2APGRSRCHDAC4
SCHEMBL5167604 0.88 MEN1 (0.55) MEN1KMT2APGRSRCHDAC4
SCHEMBL5163448 0.86 HDAC4 (0.59) MEN1KMT2APGRSRCHDAC4
SCHEMBL5167153 0.85 MEN1 (0.70) MEN1KMT2APGRSRCHDAC4
SCHEMBL5166407 0.84 MEN1 (0.58) MEN1KMT2APGRSRCHDAC4
SCHEMBL5165191 0.84 KMT2A (0.58) MEN1KMT2APGRSRCHDAC4
SCHEMBL5164479 0.84 MEN1 (0.58) MEN1KMT2APGRSRCHDAC4
SCHEMBL10677667 0.83 KMT2A (0.71) MEN1KMT2APGRSRCHDAC4
SCHEMBL7721624 0.79 EGFR (0.52) MEN1KMT2ASRCMAP3K5ALDH1A1
SCHEMBL17816198 0.76 MEN1 (0.71) MEN1KMT2APGRSRCHDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1224172-B1 DRUGS FOR THE TREATMENT OF MALIGNANT TUMOURS ACTIVE BIOTECH AB (SE) 2007-04-04 — — EP claimed
US-6395750-B1 Includes laquinimod, N-ethyl-N-phenyl-1,2-dihydro-4-hydroxy-5-chloro-1-methyl-2-oxo-quinoline-3-carboxamide and its salts; breat or prostate cancer ACTIVE BIOTECH AB (SE) 2002-05-28 — — US claimed
EP-1224172-B1 DRUGS FOR THE TREATMENT OF MALIGNANT TUMOURS ACTIVE BIOTECH AB (SE) 2007-04-04 — — EP disclosed
EP-1224172-A1 DRUGS FOR THE TREATMENT OF MALIGNANT TUMOURS Active Biotech AB (SE) 2002-07-24 — — EP disclosed
US-6395750-B1 Includes laquinimod, N-ethyl-N-phenyl-1,2-dihydro-4-hydroxy-5-chloro-1-methyl-2-oxo-quinoline-3-carboxamide and its salts; breat or prostate cancer ACTIVE BIOTECH AB (SE) 2002-05-28 — — US disclosed
WO-2001030758-A1 DRUGS FOR THE TREATMENT OF MALIGNANT TUMOURS ACTIVE BIOTECH AB (SE) 2001-05-03 — — WO disclosed
Send feedback